The governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec have recently announced that they will fund Zelboraf and the governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec have announced that they will fund Yervoy for metastatic melanoma patients that meet the criteria in each province. The MNC is continuing to work with governments in the remaining Atlantic provinces to obtain much-needed access for patients.
Sep 20, 2012 – First personalized treatment for metastatic melanoma now funded in Ontario. Read more.
Sep 18, 2012 – Another Win for Melanoma on the Heels of Ontario Government Announcement to Implement Tanning Bed Legislation for Minors. Read more.
Sep 17 – 2012 – Melanoma Network of Canada (MNC) applauds governments of Manitoba and Saskatchewan for funding first personalized treatment for metastatic melanoma – MNC wishes the Quebec government would take the same steps to allow patients access to this medical breakthrough in the treatment of metastatic melanoma. Read more.
Sep 13, 2012 – The Melanoma Network of Canada Applauds Governments of Manitoba and Saskatchewan for Funding First Personalized Treatment for Metastatic Melanoma. Read more.
Feb 16, 2012 – Health Canada approves Zelboraf (vemurafenib), a targeted medicine designed to inhibit cancer growth in patients known to have a common type of metastatic melanoma. Read the full article here.
Feb 7, 2012 – Health Canada announced today that Yervoy (ipilimumab) has been approved for use by melanoma patients. Read the full article here.
Patients Still Needed to Participate in Advocacy Campaign
Please contact the Melanoma Network of Canada today with your offer to help in the very important campaign.
email@example.com | 1-289-242-2010